These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2203501)

  • 41. Candiduria: Evidence-based approach to management, are we there yet?
    Alfouzan WA; Dhar R
    J Mycol Med; 2017 Sep; 27(3):293-302. PubMed ID: 28501465
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Standardization and demonstration of antibody-coated Candida in urine by direct immunofluorescence test.
    Talwar P; Pal SR; Kaur P; Kaiwar R; Jayashree T; Rao MS; Vaidyanathan S
    Mycopathologia; 1986 Apr; 94(1):39-44. PubMed ID: 3088453
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Urinary tract infection : clinical significance of antibody-coated bacteria].
    Yasumoto R; Iseki T; Kakinoki K; Yoshimoto M; Nishijima T; Maekawa M
    Hinyokika Kiyo; 1984 Apr; 30(4):489-92. PubMed ID: 6385663
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High prevalence of upper urinary tract involvement detected by 111indium-oxine leukocyte scintigraphy in patients with candiduria.
    Horcajada JP; Gutiérrez-Cuadra M; Martínez-Rodríguez I; Salas C; Parra JA; Benito N; Quirce R; Carril JM; Fariñas MC
    Eur J Clin Microbiol Infect Dis; 2012 Mar; 31(3):237-42. PubMed ID: 21633831
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk factors for nosocomial candiduria due to Candida glabrata and Candida albicans.
    Harris AD; Castro J; Sheppard DC; Carmeli Y; Samore MH
    Clin Infect Dis; 1999 Oct; 29(4):926-8. PubMed ID: 10589912
    [TBL] [Abstract][Full Text] [Related]  

  • 46. To treat or not to treat--critically ill patients with candiduria.
    Hollenbach E
    Mycoses; 2008 Sep; 51 Suppl 2():12-24. PubMed ID: 18721329
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Caspofungin in the treatment of symptomatic candiduria.
    Sobel JD; Bradshaw SK; Lipka CJ; Kartsonis NA
    Clin Infect Dis; 2007 Mar; 44(5):e46-9. PubMed ID: 17278048
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of candiduria in diabetic patients attending Gondar University Hospital, Gondar, Ethiopia.
    Yismaw G; Asrat D; Woldeamanuel Y; Unakal C
    Iran J Kidney Dis; 2013 Mar; 7(2):102-7. PubMed ID: 23485533
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunoglobulin levels and antibody-coated bacteria in urines from patients with urinary tract infections.
    Thomas VL; Forland M; Shelokov A
    Proc Soc Exp Biol Med; 1975 Apr; 148(4):1198-201. PubMed ID: 1093202
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Importance of immunofluorescence in localizing the site of urinary infections].
    Courteau C; Montplaisir S; Martineau B; Pelletier M
    Union Med Can; 1980 Mar; 109(3):397-407, 450-2. PubMed ID: 6990576
    [No Abstract]   [Full Text] [Related]  

  • 51. Relationship of upper and lower urinary tract infection and bacterial invasion of uroepithelium to antibody-coated bacteria test results in female dogs.
    Ling GV; Cullen JM; Kennedy PC; Ruby AL; Brooks DL
    Am J Vet Res; 1985 Feb; 46(2):499-504. PubMed ID: 3888012
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Strategy of the use of immunological tests in the topographical diagnosis of urinary infections].
    Aubert G; Adeleine P; André J; Denis M; Dorche G
    Presse Med; 1983 Nov; 12(43):2741-5. PubMed ID: 6228834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Indirect immunofluorescence assay for antibody to germ tube of Candida albicans--a new diagnostic test.
    Ho YM; Ng MH; Teoh-Chan CH; Yue PC; Huang CT
    J Clin Pathol; 1976 Nov; 29(11):1007-10. PubMed ID: 794079
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Value of antibody coated bacteria in the localization and follow-up of chronic urinary tract infections (author's transl)].
    André J; Arnaud B; Pilonchery G; Leriche A
    Ann Biol Clin (Paris); 1980; 38(2):111-4. PubMed ID: 6992658
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunodiffusion and agglutination tests for Candida in patients with neoplastic disease: inconsistent correlation of results with invasive infections.
    Filice G; Yu B; Armstrong D
    J Infect Dis; 1977 Mar; 135(3):349-57. PubMed ID: 403241
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical studies on urinary tract Candida infection with special reference to the diagnosis and treatment].
    Ohkawa M; Tokunaga S; Shoda R; Hisazumi H
    Nihon Hinyokika Gakkai Zasshi; 1987 Mar; 78(3):439-45. PubMed ID: 3656846
    [No Abstract]   [Full Text] [Related]  

  • 57. [Evaluation of risk factors in patients with candiduria].
    Nayman Alpat S; Özguneş I; Ertem OT; Erben N; Doyuk Kartal E; Tözun M; Usluer G
    Mikrobiyol Bul; 2011 Apr; 45(2):318-24. PubMed ID: 21644075
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The significance of candiduria.
    Umenai T; Ishida N
    Tohoku J Exp Med; 1977 May; 122(1):59-63. PubMed ID: 918955
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Immunofluorescence detection of antibody-coated bacteria (ACB) and its application in the localization of urinary tract infection (author's transl)].
    Cai BJ
    Zhonghua Wai Ke Za Zhi; 1982 Apr; 20(4):195-7. PubMed ID: 7049624
    [No Abstract]   [Full Text] [Related]  

  • 60. Antibody-coated bacteria in the urine of children with urinary tract infections.
    Forsum U; Hjelm E; Jonsell G
    Acta Paediatr Scand; 1976 Sep; 65(5):639-42. PubMed ID: 785940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.